| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.26B | 49.91B | 48.73B | 43.23B | 44.01B | 47.00B |
| Gross Profit | 16.09B | 16.53B | 15.60B | 12.20B | 12.61B | 14.14B |
| EBITDA | 5.55B | 5.96B | 5.47B | 3.88B | 3.29B | 4.81B |
| Net Income | 2.08B | 2.61B | 2.21B | 999.00M | 332.00M | 1.93B |
Balance Sheet | ||||||
| Total Assets | 62.76B | 62.77B | 63.36B | 61.02B | 61.84B | 65.04B |
| Cash, Cash Equivalents and Short-Term Investments | 14.00B | 15.55B | 14.54B | 13.44B | 10.91B | 11.38B |
| Total Debt | 9.98B | 6.85B | 9.90B | 11.49B | 11.86B | 14.44B |
| Total Liabilities | 25.60B | 21.82B | 25.45B | 26.39B | 28.75B | 32.99B |
| Stockholders Equity | 34.93B | 38.46B | 35.72B | 32.63B | 31.23B | 30.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.61B | 3.11B | 2.43B | 1.46B | 1.76B |
| Operating Cash Flow | 0.00 | 5.57B | 4.11B | 5.37B | 3.61B | 4.30B |
| Investing Cash Flow | 0.00 | -1.31B | -1.21B | -2.44B | -2.15B | -2.36B |
| Financing Cash Flow | 0.00 | -3.70B | -2.54B | -1.26B | -3.21B | -4.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥52.46B | 25.62 | 9.07% | 4.46% | 3.09% | 22.56% | |
69 Neutral | ¥53.06B | -711.15 | ― | 4.32% | -19.49% | -101.29% | |
67 Neutral | ¥28.22B | 39.81 | ― | 3.21% | 2.43% | 17.77% | |
63 Neutral | ¥299.61B | 20.15 | 9.45% | 2.65% | 1.87% | -5.06% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥894.89B | -17.36 | -2.50% | 3.49% | -4.57% | -190.44% | |
56 Neutral | ¥331.00B | 32.98 | 6.95% | 3.06% | -6.88% | ― |